Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Three DPP-4 Inhibitors in T2D
NCT02089438Phase 4Completed
- Sponsor
- Lund University
- Start
- May 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of saxagliptin, sitagliptin and vildagliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Lund University. Primary endpoint: Postprandial glucose. Started May 2014; status: completed.
02
Drugs
saxagliptinsitagliptinvildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02089438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089438.